Tofacitinib in Depression (TIDE)

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

February 10, 2020

Primary Completion Date

May 23, 2022

Study Completion Date

May 23, 2022

Conditions
DepressionInflammation
Interventions
DRUG

Tofacitinib 5 MG [Xeljanz]

Tofacitinib 5mg capsules twice a day for 7-10 days

OTHER

Placebo

Placebo capsules twice a day for 7-10 days

Trial Locations (1)

OX3 7JX

Department of Psychiatry, University of Oxford, Oxford

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Wellcome Trust

OTHER

collaborator

Medical Research Council

OTHER_GOV

lead

University of Oxford

OTHER

NCT04141904 - Tofacitinib in Depression (TIDE) | Biotech Hunter | Biotech Hunter